Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 01, 2022 08:30 ET | Source: Digital Ally Inc.

Digital Ally Subsidiary TicketSmarter®, a Primary and Secondary Ticketing Platform, Announces Primary Ticketing and Naming Rights Partnership

Future Legends Complex and TicketSmarter Stadium will host professional sporting events and concerts broadcasted across national media outlets Lenexa, KS, April 01, 2022 (GLOBE NEWSWIRE) -- Digital...
March 31, 2022 13:54 ET | Source: TicketSmarter

Future Legends Complex Announces Stadium Naming Rights and Ticket Sales Partnership with TicketSmarter

WINDSOR, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- Future Legends Complex and TicketSmarter have announced an agreement to name the complex’s centerpiece 6,500-seat main professional sports stadium...
March 30, 2022 13:24 ET | Source: Goodman & Company, Investment Counsel Inc.

CMP 2022 Resource Limited Partnership Completes $14,135,000 IPO

TORONTO, March 30, 2022 (GLOBE NEWSWIRE) -- Goodman & Company, Investment Counsel Inc. (the “Manager”) is pleased to announce that CMP 2022 Resource Limited Partnership (the “Partnership”) has...
March 30, 2022 06:00 ET | Source: Prime Mining Corp.

Prime Mining Appoints Chantal Gosselin to the Board of Directors

VANCOUVER, British Columbia, March 30, 2022 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime”, or the “Company”) (TSX.V: PRYM) (OTCQB: PRMNF) (Frankfurt: O4V3) is pleased to announce the appointment...
March 28, 2022 22:36 ET | Source: Dundee Corporation

Dundee Corporation Makes Significant Progress on Strategic Initiatives and Announces Fourth Quarter and Year End 2021 Financial Results

TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announced its financial results for the three months and year ended December 31,...
March 25, 2022 08:30 ET | Source: POINT Biopharma

POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update

Reported 27-patient dosimetry data from the lead-in cohort of the SPLASH trial Randomization phase of SPLASH trial ongoing, top line data expected mid-2023 Phase 1 therapeutic trial for PNT6555, the...
March 24, 2022 07:30 ET | Source: Thérapeutique Knight inc.

Thérapeutique Knight publie ses résultats du quatrième trimestre et de fin d’année 2021 et ses perspectives financières pour 2022

MONTRÉAL, 24 mars 2022 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou « la Société »), société pharmaceutique spécialisée panaméricaine (hors ÉU) et chef de file, a...
March 24, 2022 07:30 ET | Source: Knight Therapeutics

Knight Therapeutics Reports Fourth Quarter and Year-End 2021 Results and Provides 2022 Revenue Guidance

MONTREAL, March 24, 2022 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading Pan-American (ex-US) specialty pharmaceutical company, today reported...
March 22, 2022 10:00 ET | Source: Experimental Biology and Medicine

Using Ultrasound to Treat Dry Eye Disease

WASHINGTON, March 22, 2022 (GLOBE NEWSWIRE) -- A recently published article in Experimental Biology and Medicine (Volume 247, Issue 6, March, 2022) describes a novel treatment for dry eye disease...
March 17, 2022 17:01 ET | Source: Dundee Corporation

Dundee Corporation Renews Normal Course Issuer Bids on Three Share Classes

TORONTO, March 17, 2022 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A, DC.PR.B, DC.PR.D) (“Dundee” or the “Company”) announced today receipt of regulatory approval for its notice of intention to...